全球原代细胞培养市场规模、份额、趋势及成长分析报告（2026-2034年）

预计到 2034 年，原代细胞培养市场规模将从 2025 年的 30.1 亿美元成长至 76.3 亿美元，2026 年至 2034 年的复合年增长率为 10.9%。

随着研究人员在药物研发和疾病研究中越来越依赖生理相关的细胞模型，全球原代细胞培养市场正在扩张。与永生化细胞株相比，原代细胞培养具有更高的生物学精确性，因此对转化研究至关重要。再生医学和毒性测试应用领域日益增长的需求也推动了市场的持续成长。

成长要素包括：针对人类相关临床模型的监管激励措施、细胞分离和冷冻保存技术的进步，以及个人化医疗研究的扩展。供体特异性和疾病特异性原代细胞培养物的日益普及提高了研究的准确性。供应商与研究机构之间的合作也有助于提高细胞培养物的可及性和产品品质。

未来的成长机会在于与类器官系统、3D培养和微生理平台的整合。临床应用对符合GMP标准的原代培养细胞的需求预计将会成长。能够确保符合伦理的采购、认证和可扩展性的供应商将在不断变化的市场格局中获得竞争优势。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球原代细胞培养市场：依来源划分

• 市场分析、洞察与预测
• 人类原代培养细胞
• 动物性原代培养细胞

第五章：全球原代细胞培养市场：依类型划分

• 市场分析、洞察与预测
• 造血细胞
• 皮肤细胞
• 肝细胞
• 胃肠道细胞
• 肺细胞
• 肾臟细胞
• 心肌细胞
• 骨骼肌细胞和横纹肌细胞
• 其他原代培养细胞

第六章：全球原代细胞培养市场：依应用划分

• 市场分析、洞察与预测
• 药物发现与开发
• 再生医学
• 癌症研究
• 其他的

第七章 全球原代细胞培养市场：依最终用户划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 学术研究机构
• CRO

第八章：全球原代细胞培养市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza
  • Cell Biologics Inc
  • PromoCell
  • ZenBio
  • Stemcell Technologies
  • AllCells
  • American Type Culture Collection
  • Axol Biosciences Ltd

The Primary Cells Market size is expected to reach USD 7.63 Billion in 2034 from USD 3.01 Billion (2025) growing at a CAGR of 10.9% during 2026-2034.

The Global Primary Cells market is expanding as researchers increasingly rely on physiologically relevant cell models for drug discovery and disease research. Primary cells offer improved biological accuracy compared to immortalized cell lines, making them essential for translational studies. Rising demand from regenerative medicine and toxicity testing applications supports consistent market growth.

Growth drivers include regulatory encouragement for human-relevant testing models, improved isolation and cryopreservation techniques, and expansion of personalized medicine research. Increasing availability of donor-specific and disease-state primary cells strengthens research precision. Partnerships between suppliers and research institutions also enhance accessibility and product quality.

Future opportunities lie in integration with organoid systems, 3D cultures, and microphysiological platforms. Demand for GMP-grade primary cells for clinical applications will rise. Suppliers that ensure ethical sourcing, authentication, and scalability will gain competitive advantage in this evolving market landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Origin

• Human Primary Cells
• Animal Primary Cells

By Type

• Hematopoietic Cells
• Skin Cells
• Hepatocytes
• Gastrointestinal Cells
• Lung Cells
• Renal Cells
• Heart Cells
• Skeletal and Muscle Cells
• Other Primary Cells

By Application

• Drug Discovery and Development
• Regenerative Medicine
• Cancer Research
• Others

By End User

• Pharmaceuticals & Biotechnology Companies
• Academic & Research Institutes
• CROs

COMPANIES PROFILED

• Thermo Fisher Scientific, Merck KGaA, Lonza, Cell Biologics Inc, PromoCell, ZenBio, Stemcell Technologies, AllCells, American Type Culture Collection, Axol Biosciences Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRIMARY CELLS MARKET: BY ORIGIN 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Origin
• 4.2. Human Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Animal Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRIMARY CELLS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Hematopoietic Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Skin Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hepatocytes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Gastrointestinal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Lung Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Renal Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Heart Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Skeletal and Muscle Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Other Primary Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRIMARY CELLS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery and Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cancer Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRIMARY CELLS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceuticals & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PRIMARY CELLS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Origin
  • 8.2.2 By Type
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Origin
  • 8.3.2 By Type
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Origin
  • 8.4.2 By Type
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Origin
  • 8.5.2 By Type
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Origin
  • 8.6.2 By Type
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PRIMARY CELLS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Thermo Fisher Scientific
  • 10.2.2 Merck KGaA
  • 10.2.3 Lonza
  • 10.2.4 Cell Biologics Inc
  • 10.2.5 PromoCell
  • 10.2.6 ZenBio
  • 10.2.7 Stemcell Technologies
  • 10.2.8 AllCells
  • 10.2.9 American Type Culture Collection
  • 10.2.10 Axol Biosciences Ltd